Opus Genetics (IRD) traded down -9.16 % during a 24 hours period ending at 01:18 AM Central Europe on Tuesday 27th. One Opus Genetics stock can currently be bought for about USD 3.32 on popular exchanges. Current supply of Opus Genetics stocks is 83.2 mn. Opus Genetics has a current market capitalization of USD 288.7 mn and approximately USD 3.9 mn worth of Opus Genetics was traded on exchanges in the last 24 hours. Since last month end, Opus Genetics has traded -28.75 % down. Simple moving average of last 200 days is at USD 4.14. The highest price of past 52 weeks was recorded at USD 7.07 on 09/09/2026. 52 weeks low was at USD 1.7 on 11/18/2025.
Here is how related stocks have performed in the past 24 hours:
Primeenergy (PNRG) traded up 6.74 % and now trades at USD 218.17. Current market capitalisation for Primeenergy is USD 341.4 mn. Primeenergy has a current price to earnings ratio of 20.48.
Iheartmedia (IHRT) traded up 8.72 % and now trades at USD 1.77. Iheartmedia has a market capitalisation of USD 341.3 mn.
Flexsteel Inds (FLXS) traded down -0.94 % and now trades at USD 82.55. Current market capitalisation for Flexsteel Inds is USD 344.4 mn. Flexsteel Inds has a current price to earnings ratio of 13.8.
Stitch Fix (SFIX) traded down -5.88 % and now trades at USD 2.62. Stitch Fix has a market capitalisation of USD 342 mn.
Capricor Therapeutics (CAPR) traded down -3.26 % and now trades at USD 5.74. Capricor Therapeutics has a market capitalisation of USD 344.8 mn.
About Opus Genetics
Ocuphire Pharma, Inc. is a clinical-stage ophthalmic biopharmaceutical company that specializes in developing and commercializing therapies for the treatment of several eye disorders. As a health care biotechnology company, it operates in the Farmington Hills sector and has its main operations in the United States. The company serves customers globally through its official website (www.ocuphire.com ) and Nasdaq stock exchange.
